FindTrial
Sign In

Intestinal microbiota mediates iNKT cells by regulating CCL25/CCR9 interaction in the inflammatory bowel disease

Intestinal microbiota mediates iNKT cells by regulating CCL25/CCR9 interaction in the inflammatory bowel disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-COC-17013206
Enrollment
Unknown
Registered
2017-11-01
Start date
2018-01-01
Completion date
Unknown
Last updated
2017-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory bowel disease

Interventions

Case series:Nil

Sponsors

Beijing Friendship Hospital Affiliated to Captial Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1) Signed informed consent; 2) Diagnosed definitively; 3) Age 18 to 55 years old; 4) No probiotics have been taken in 3 months.;Inclusion criteria: 1) Signed informed consent; 2) Diagnosed definitively; 3) Age 18 to 55 years old; 4) No probiotics have been taken in 3 months.;Inclusion criteria: 1) Signed informed consent; 2) Diagnosed definitively; 3) Age 18 to 55 years old; 4) No probiotics have been taken in 3 months.;Inclusion criteria: 1) Signed informed consent; 2) Diagnosed definitively; 3) Age 18 to 55 years old; 4) No probiotics have been taken in 3 months.;Inclusion criteria: 1) Signed informed consent; 2) Diagnosed definitively; 3) Age 18 to 55 years old; 4) No probiotics have been taken in 3 months.

Exclusion criteria

Exclusion criteria: 1) Any probiotics has been taken in 3 months; 2) Infectious colitis patients; 3) Non-infectious colitis patients; 4) Neoplastic disease patients.;Exclusion criteria: 1) Any probiotics has been taken in 3 months; 2) Infectious colitis patients; 3) Non-infectious colitis patients; 4) Neoplastic disease patients.;Exclusion criteria: 1) Any probiotics has been taken in 3 months; 2) Infectious colitis patients; 3) Non-infectious colitis patients; 4) Neoplastic disease patients.;Exclusion criteria: 1) Any probiotics has been taken in 3 months; 2) Infectious colitis patients; 3) Non-infectious colitis patients; 4) Neoplastic disease patients.;Exclusion criteria: 1) Any probiotics has been taken in 3 months; 2) Infectious colitis patients; 3) Non-infectious colitis patients; 4) Neoplastic disease patients.

Design outcomes

Primary

MeasureTime frame
CCL25/CCR9 interaction;—

Countries

China

Contacts

Public ContactSiying Zhu;Siying Zhu;Siying Zhu;Siying Zhu;Siying Zhu ;;;;

Beijing Friendship Hospital Affiliated to Captial Medical University;Beijing Friendship Hospital Affiliated to Captial Medical University;Beijing Friendship Hospital Affiliated to Captial Medical University;Beijing Friendship Hospital Affiliated to Captial Medical University;Beijing Friendship Hospital Affiliated to Captial Medical University

siying-sky@163.com;siying-sky@163.com;siying-sky@163.com;siying-sky@163.com;siying-sky@163.com+86 13522412521;+86 13522412521;+86 13522412521;+86 13522412521;+86 13522412521

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026